IL55660A0 - Pharmaceutical compositions including a certain penicillinderivative and an anhancing agent therefor - Google Patents

Pharmaceutical compositions including a certain penicillinderivative and an anhancing agent therefor

Info

Publication number
IL55660A0
IL55660A0 IL7855660A IL5566078A IL55660A0 IL 55660 A0 IL55660 A0 IL 55660A0 IL 7855660 A IL7855660 A IL 7855660A IL 5566078 A IL5566078 A IL 5566078A IL 55660 A0 IL55660 A0 IL 55660A0
Authority
IL
Israel
Prior art keywords
penicillinderivative
anhancing
certain
pharmaceutical compositions
compositions including
Prior art date
Application number
IL7855660A
Other versions
IL55660A (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL55660(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IL55660A0 publication Critical patent/IL55660A0/en
Publication of IL55660A publication Critical patent/IL55660A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
IL55660A 1977-10-11 1978-09-28 Pharmaceutical compositions containing amoxycillin trihydrate and potassium clavulanate IL55660A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (2)

Publication Number Publication Date
IL55660A0 true IL55660A0 (en) 1978-12-17
IL55660A IL55660A (en) 1981-09-13

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
IL55660A IL55660A (en) 1977-10-11 1978-09-28 Pharmaceutical compositions containing amoxycillin trihydrate and potassium clavulanate

Country Status (24)

Country Link
US (2) US4441609A (en)
JP (1) JPS5476831A (en)
AU (1) AU525089B2 (en)
BE (1) BE870988A (en)
CA (1) CA1105385A (en)
CH (1) CH642258A5 (en)
DE (1) DE2843318A1 (en)
FR (1) FR2405711A1 (en)
GB (1) GB2005538B (en)
HK (1) HK73785A (en)
IE (1) IE47450B1 (en)
IL (1) IL55660A (en)
IT (1) IT1109273B (en)
JO (1) JO984B1 (en)
KE (1) KE3525A (en)
MT (1) MTP836B (en)
MY (1) MY8500996A (en)
NL (1) NL190631B (en)
NZ (1) NZ188497A (en)
PL (1) PL210174A1 (en)
PT (1) PT68600A (en)
SE (2) SE435899B (en)
SG (1) SG34985G (en)
ZA (1) ZA785682B (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
AT353409B (en) * 1975-02-07 1979-11-12 Glaxo Lab Ltd METHOD OF REMOVING CONTAMINATION FROM CLAVULANIC ACID OR THEIR SALT
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ194912A (en) 1979-10-02 1983-05-31 Beecham Group Ltd 6 -(2-(2'-methylphenoxycarbonyl)-2-thien-3'-ylacetamido)-penicillanic acid and pharmaceutical compositions
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (en) * 1986-01-22 1988-12-23 Adir WATERPROOF PACKAGING IN THE FORM OF ALVEOLAR PLATES ALLOWING FOR GAS EXCHANGES BETWEEN THE ALVEOLES.
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
US5947274A (en) * 1994-08-05 1999-09-07 Smithkline Beecham P.L.C. Desiccating container for moisture-sensitive material
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (en) 1995-05-03 2002-10-23 Smithkline Beecham Plc Medicines used to treat bacterial infections in pediatrics.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
KR100495585B1 (en) 1995-09-07 2005-09-09 스미스클라인비이참피이엘시이 Pharmaceutical Formulation
AT403375B (en) * 1995-11-15 1998-01-26 Biochemie Gmbh METHOD FOR FILLING ALKALINE SALTS OF CLAVULANIC ACID
ITMI952354A1 (en) * 1995-11-16 1997-05-16 Smithkline Beecham Spa PHARMACEUTICAL COMPOSITION
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407214B (en) * 1996-03-13 2001-01-25 Biochemie Gmbh Process for the preparation of excipient-free agglomerates of beta-lactam antibiotics
AT407701B (en) * 1996-08-12 2001-05-25 Biochemie Gmbh Mixture which is suitable for direct tableting and contains as essential components amoxicillin trihydrate and the calcium salt of clavulanic acid, and process for preparing this mixture
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
IL131201A (en) * 1997-02-14 2005-06-19 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxycillin and clavulanate
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
BR0013366A (en) * 1999-08-16 2002-07-23 Revaax Pharmaceuticals Llc Methods to treat a behavioral disorder, a human patient, prostate disease, anxiety and cognitive disorders in a human patient afflicted with a condition or willing to develop a condition distinguished at least in part by the concentration of abnormal extracellular glutamate in the brain or in other nervous tissue, behavioral disorder in human, canine, feline and equine species and a patient afflicted with or willing to develop a disease comprising abnormally high glutamate concentrations in neuronal tissue or elevated naaladase levels in prostate tissue and with multiple sclerosis and to enhance cognitive function, pharmaceutical formulation and uses of an inhibitor of peptidase activity of an acidic dipeptidase bound in n-acetylated alpha and a beta-lactam compound
SI20411A (en) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Watersoluble powders for peroral solution and their use
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (en) * 2000-05-30 2004-11-25 Sandoz Ag METHOD FOR DRYING AMOXICILLIN OR AMOXICILLIN-CONTAINING, ORAL, SOLID PHARMACEUTICAL COMPOSITIONS USING A GAS WITH A DEFINED GAS HUMIDITY
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US20060039967A1 (en) * 2002-08-12 2006-02-23 Motohiro Ohta Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (en) * 2006-02-17 2007-08-30 Grünenthal GmbH Storage-stable oral dosage form of amoxicillin and clavulanic acid
US9458451B2 (en) 2007-06-21 2016-10-04 Gen-Probe Incorporated Multi-channel optical measurement instrument
JP2011500811A (en) * 2007-10-26 2011-01-06 レクサン ファーマシューティカルズ インコーポレイテッド Clavulanic acid pharmaceutical formulation
JP2012525427A (en) * 2009-04-29 2012-10-22 レクサン ファーマシューティカルズ インコーポレイテッド Clavulanate formulation for neuroprotection and treatment of neurodegenerative diseases
TR200909787A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Pharmaceutical formulations containing a third generation cephalosporin and clavulanic acid.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus

Also Published As

Publication number Publication date
IT7851415A0 (en) 1978-10-09
US4441609A (en) 1984-04-10
SE451668B (en) 1987-10-26
GB2005538A (en) 1979-04-25
FR2405711A1 (en) 1979-05-11
IE47450B1 (en) 1984-03-21
DE2843318A1 (en) 1979-04-12
AU4050678A (en) 1980-04-17
SE435899B (en) 1984-10-29
FR2405711B1 (en) 1982-10-29
SG34985G (en) 1985-11-15
AU525089B2 (en) 1982-10-21
PL210174A1 (en) 1980-08-11
SE8107592L (en) 1981-12-17
IL55660A (en) 1981-09-13
CA1105385A (en) 1981-07-21
NL7810176A (en) 1979-04-17
IE782019L (en) 1979-04-11
JO984B1 (en) 1979-12-01
CH642258A5 (en) 1984-04-13
ZA785682B (en) 1979-09-26
HK73785A (en) 1985-10-04
SE7810591L (en) 1979-04-11
BE870988A (en) 1979-04-03
JPS6341886B2 (en) 1988-08-19
PT68600A (en) 1978-10-01
KE3525A (en) 1985-05-31
US4301149A (en) 1981-11-17
JPS5476831A (en) 1979-06-19
MY8500996A (en) 1985-12-31
MTP836B (en) 1979-05-11
NZ188497A (en) 1981-05-01
GB2005538B (en) 1982-05-26
NL190631B (en) 1994-01-03
IT1109273B (en) 1985-12-16

Similar Documents

Publication Publication Date Title
IL55660A0 (en) Pharmaceutical compositions including a certain penicillinderivative and an anhancing agent therefor
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
JPS53109934A (en) Pharmaceutical composition
NZ186965A (en) Guanidino derivatives and pharmaceutical compositions
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ186677A (en) 4-acylaminophenylethanolamines and pharmaceutical compositions conaining them
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
NZ186692A (en) Morphine derivatives and pharmaceutical compositions
NZ189246A (en) 4-spectinomycylamine its salts and pharmaceutical compositions
DE2862107D1 (en) Glucosamine-peptide derivatives and their pharmaceutical compositions
NZ187909A (en) 3-(indol-4-yloxy)-1-substitutedaminopropan-2-ols and pharmaceutical compositions
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
NZ188798A (en) 2-iminoimidazolidine derivatives and pharmaceutical compositions
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
NZ187876A (en) Tetraline derivatives and pharmaceutical compositions
NZ186693A (en) Morphine derivatives and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
NZ186689A (en) Substituted bis-benzimidazolyl compounds and pharmaceutical compositions
JPS5470255A (en) Nnbenzylanthracycline and pharmaceutical composition
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol